Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.76% | $301.78M | €458.38B | 86.92% | 76 Outperform | |
| Novartis AG | 1.80% | $196.62M | CHF232.19B | 30.93% | 80 Outperform | |
| HSBC Holdings | 1.32% | $143.94M | £219.84B | 52.09% | 80 Outperform | |
| Roche Holding AG | 1.29% | $140.72M | CHF268.16B | 29.32% | 73 Outperform | |
| AstraZeneca | 1.21% | $132.64M | $305.49B | 27.65% | 80 Outperform | |
| SAP SE | 1.21% | $131.98M | €193.11B | -29.30% | 66 Neutral | |
| Nestlé SA | 1.20% | $131.49M | CHF201.30B | 0.07% | 71 Outperform | |
| Siemens | 1.08% | $117.67M | €176.96B | 2.09% | 74 Outperform | |
| Schneider Electric | 0.97% | $106.39M | €143.65B | 13.41% | 62 Neutral | |
| Commonwealth Bank of Australia | 0.97% | $105.61M | AU$287.21B | 16.93% | 64 Neutral |